Feasibility and safety of short-duration aerobic training in non-hematological cancer patients hospitalized for chemotherapy treatment
The Oncologist · 10.04.2026 · 31 (5)
DOI: 10.1093/oncolo/oyag117 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 08.04.2026. Verfasst von William de Lima Selles und 5 weiteren Autor:innen. Beteiligte Einrichtung: Master's and Doctoral Programs in Physical Therapy, Universidade Cidade de São Paulo, São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Neoplasms, Exercise, Exercise Therapy. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundação de Amparo à Pesquisa de São Paulo.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
It is unclear whether moderate-intensity aerobic exercise is feasible and safe for inpatients with non-hematological cancer receiving one cycle of chemotherapy.
Objectives
To evaluate adherence, compliance, acceptability, adverse events, and clinical stability during a short-term moderate-intensity aerobic training in non-hematological inpatients undergoing one cycle of chemotherapy.
Methods
This feasibility and safety study included adults with non-hematological cancer inpatients receiving one cycle of chemotherapy. Patients participated in four consecutive days of moderate-intensity aerobic training using a cycle ergometer, during which vital signs and perceived exertion were monitored. Following the intervention, patients were assessed for the acceptability of intervention. Adherence rates, compliance, and adverse events related to the training were also recorded.
Results
Twenty patients (mean age 61 ± 15 years, mean BMI 25 ± 8 kg/m2; 75% with digestive cancers, 50% physically active) were analyzed. Adherence to the intervention was 92%, compliance was 68.6%, and acceptability was reported at 100%. Vital signs and perceived exertion remained stable throughout all training sessions (heart rate P = .99, peripheral O2 saturation P = .54, mean arterial blood pressure P = .79, sensation of dyspnea P = .97). Two patients reported adverse events during training (vomiting and extreme fatigue), while three experienced adverse effects post-training (tremor, nausea, and back pain).
Conclusions
Short-term moderate-intensity aerobic training for inpatients with non-hematological cancer undergoing one cycle of chemotherapy is feasible and safe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Master's and Doctoral Programs in Physical Therapy, Universidade Cidade de São Paulo, São Paulo, SP, Brazil.
- Division of Physical Therapy, School of Medicine, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
ORCID-Profile: William de Lima Selles, Adriana Claudia Lunardi
Förderung
- Fundação de Amparo à Pesquisa de São Paulo
Zitieren
APA
Selles, W. L., Pereira, L. J. F., Moura, G. M., Lima, B. M., Wisnieski da Silva, D., & Lunardi, A. C. (2026). Feasibility and safety of short-duration aerobic training in non-hematological cancer patients hospitalized for chemotherapy treatment. The Oncologist, 31(5). https://doi.org/10.1093/oncolo/oyag117
Vancouver
Selles WL, Pereira LJF, Moura GM, Lima BM, Wisnieski da Silva D, Lunardi AC. Feasibility and safety of short-duration aerobic training in non-hematological cancer patients hospitalized for chemotherapy treatment. The Oncologist. 2026;31(5). doi:10.1093/oncolo/oyag117
BibTeX
@article{Selles2026,
author = {Selles, William de Lima and Pereira, Leticia Jeremias Ferreira and Moura, Giovanni Marini and Lima, Beatriz Marques and Wisnieski da Silva, Diego and Lunardi, Adriana Claudia},
title = {Feasibility and safety of short-duration aerobic training in non-hematological cancer patients hospitalized for chemotherapy treatment},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {5},
doi = {10.1093/oncolo/oyag117}
}
EUVIMED